nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—SLC22A7—Methotrexate—lymphatic system cancer	0.134	0.202	CbGbCtD
Enalapril—SLCO1A2—Methotrexate—lymphatic system cancer	0.0938	0.142	CbGbCtD
Enalapril—SLC22A8—Methotrexate—lymphatic system cancer	0.0817	0.124	CbGbCtD
Enalapril—ABCB1—Mitoxantrone—lymphatic system cancer	0.0609	0.0921	CbGbCtD
Enalapril—SLC22A6—Methotrexate—lymphatic system cancer	0.0569	0.0861	CbGbCtD
Enalapril—CYP3A4—Cytarabine—lymphatic system cancer	0.0529	0.0801	CbGbCtD
Enalapril—CYP3A4—Teniposide—lymphatic system cancer	0.0521	0.0789	CbGbCtD
Enalapril—ABCB1—Vincristine—lymphatic system cancer	0.0419	0.0634	CbGbCtD
Enalapril—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0365	0.0552	CbGbCtD
Enalapril—ABCB1—Methotrexate—lymphatic system cancer	0.0254	0.0384	CbGbCtD
Enalapril—CYP3A4—Vincristine—lymphatic system cancer	0.0251	0.038	CbGbCtD
Enalapril—Paraesthesia—Fludarabine—lymphatic system cancer	0.000696	0.00205	CcSEcCtD
Enalapril—Dyspnoea—Fludarabine—lymphatic system cancer	0.000691	0.00204	CcSEcCtD
Enalapril—Dyspepsia—Fludarabine—lymphatic system cancer	0.000683	0.00201	CcSEcCtD
Enalapril—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000679	0.002	CcSEcCtD
Enalapril—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000675	0.00199	CcSEcCtD
Enalapril—Decreased appetite—Fludarabine—lymphatic system cancer	0.000674	0.00199	CcSEcCtD
Enalapril—Visual impairment—Carmustine—lymphatic system cancer	0.000673	0.00199	CcSEcCtD
Enalapril—Fatigue—Fludarabine—lymphatic system cancer	0.000668	0.00197	CcSEcCtD
Enalapril—Constipation—Fludarabine—lymphatic system cancer	0.000663	0.00196	CcSEcCtD
Enalapril—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000661	0.00195	CcSEcCtD
Enalapril—Vasculitis—Methotrexate—lymphatic system cancer	0.00066	0.00195	CcSEcCtD
Enalapril—Hypersensitivity—Teniposide—lymphatic system cancer	0.00065	0.00192	CcSEcCtD
Enalapril—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000649	0.00192	CcSEcCtD
Enalapril—Flushing—Carmustine—lymphatic system cancer	0.000648	0.00191	CcSEcCtD
Enalapril—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000644	0.0019	CcSEcCtD
Enalapril—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.000644	0.0019	CcSEcCtD
Enalapril—Anaemia—Bleomycin—lymphatic system cancer	0.000644	0.0019	CcSEcCtD
Enalapril—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000639	0.00189	CcSEcCtD
Enalapril—Asthenia—Teniposide—lymphatic system cancer	0.000633	0.00187	CcSEcCtD
Enalapril—Melaena—Methotrexate—lymphatic system cancer	0.000629	0.00186	CcSEcCtD
Enalapril—Pruritus—Teniposide—lymphatic system cancer	0.000624	0.00184	CcSEcCtD
Enalapril—Arrhythmia—Carmustine—lymphatic system cancer	0.000624	0.00184	CcSEcCtD
Enalapril—Leukopenia—Bleomycin—lymphatic system cancer	0.000624	0.00184	CcSEcCtD
Enalapril—Alopecia—Carmustine—lymphatic system cancer	0.000617	0.00182	CcSEcCtD
Enalapril—Body temperature increased—Fludarabine—lymphatic system cancer	0.000613	0.00181	CcSEcCtD
Enalapril—Erythema—Carmustine—lymphatic system cancer	0.000608	0.00179	CcSEcCtD
Enalapril—Cough—Bleomycin—lymphatic system cancer	0.000608	0.00179	CcSEcCtD
Enalapril—Diarrhoea—Teniposide—lymphatic system cancer	0.000604	0.00178	CcSEcCtD
Enalapril—Chest pain—Bleomycin—lymphatic system cancer	0.000593	0.00175	CcSEcCtD
Enalapril—Myalgia—Bleomycin—lymphatic system cancer	0.000593	0.00175	CcSEcCtD
Enalapril—Alopecia—Vincristine—lymphatic system cancer	0.000589	0.00174	CcSEcCtD
Enalapril—Back pain—Carmustine—lymphatic system cancer	0.000588	0.00174	CcSEcCtD
Enalapril—Discomfort—Bleomycin—lymphatic system cancer	0.000586	0.00173	CcSEcCtD
Enalapril—Urine output increased—Methotrexate—lymphatic system cancer	0.000582	0.00172	CcSEcCtD
Enalapril—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00058	0.00171	CcSEcCtD
Enalapril—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000576	0.0017	CcSEcCtD
Enalapril—Alopecia—Mitoxantrone—lymphatic system cancer	0.000574	0.00169	CcSEcCtD
Enalapril—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000573	0.00169	CcSEcCtD
Enalapril—Confusional state—Bleomycin—lymphatic system cancer	0.000573	0.00169	CcSEcCtD
Enalapril—Vision blurred—Carmustine—lymphatic system cancer	0.000573	0.00169	CcSEcCtD
Enalapril—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000571	0.00169	CcSEcCtD
Enalapril—Tremor—Carmustine—lymphatic system cancer	0.00057	0.00168	CcSEcCtD
Enalapril—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000568	0.00168	CcSEcCtD
Enalapril—Oedema—Bleomycin—lymphatic system cancer	0.000568	0.00168	CcSEcCtD
Enalapril—Erythema—Mitoxantrone—lymphatic system cancer	0.000565	0.00167	CcSEcCtD
Enalapril—Anaemia—Carmustine—lymphatic system cancer	0.000562	0.00166	CcSEcCtD
Enalapril—Back pain—Vincristine—lymphatic system cancer	0.000561	0.00166	CcSEcCtD
Enalapril—Vomiting—Teniposide—lymphatic system cancer	0.000561	0.00166	CcSEcCtD
Enalapril—Agitation—Carmustine—lymphatic system cancer	0.000559	0.00165	CcSEcCtD
Enalapril—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000557	0.00164	CcSEcCtD
Enalapril—Asthenia—Fludarabine—lymphatic system cancer	0.000556	0.00164	CcSEcCtD
Enalapril—Rash—Teniposide—lymphatic system cancer	0.000556	0.00164	CcSEcCtD
Enalapril—Dermatitis—Teniposide—lymphatic system cancer	0.000556	0.00164	CcSEcCtD
Enalapril—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000554	0.00163	CcSEcCtD
Enalapril—Headache—Teniposide—lymphatic system cancer	0.000553	0.00163	CcSEcCtD
Enalapril—Pruritus—Fludarabine—lymphatic system cancer	0.000549	0.00162	CcSEcCtD
Enalapril—Back pain—Mitoxantrone—lymphatic system cancer	0.000547	0.00161	CcSEcCtD
Enalapril—Leukopenia—Carmustine—lymphatic system cancer	0.000544	0.00161	CcSEcCtD
Enalapril—Anorexia—Bleomycin—lymphatic system cancer	0.000542	0.0016	CcSEcCtD
Enalapril—Anaemia—Vincristine—lymphatic system cancer	0.000536	0.00158	CcSEcCtD
Enalapril—Agitation—Vincristine—lymphatic system cancer	0.000533	0.00157	CcSEcCtD
Enalapril—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000533	0.00157	CcSEcCtD
Enalapril—Photosensitivity—Methotrexate—lymphatic system cancer	0.000533	0.00157	CcSEcCtD
Enalapril—Polyuria—Methotrexate—lymphatic system cancer	0.000533	0.00157	CcSEcCtD
Enalapril—Hypotension—Bleomycin—lymphatic system cancer	0.000531	0.00157	CcSEcCtD
Enalapril—Diarrhoea—Fludarabine—lymphatic system cancer	0.00053	0.00157	CcSEcCtD
Enalapril—Nausea—Teniposide—lymphatic system cancer	0.000524	0.00155	CcSEcCtD
Enalapril—Anaemia—Mitoxantrone—lymphatic system cancer	0.000522	0.00154	CcSEcCtD
Enalapril—Vertigo—Vincristine—lymphatic system cancer	0.000521	0.00154	CcSEcCtD
Enalapril—Hepatic failure—Methotrexate—lymphatic system cancer	0.00052	0.00154	CcSEcCtD
Enalapril—Leukopenia—Vincristine—lymphatic system cancer	0.00052	0.00153	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000518	0.00153	CcSEcCtD
Enalapril—Chest pain—Carmustine—lymphatic system cancer	0.000518	0.00153	CcSEcCtD
Enalapril—Myalgia—Carmustine—lymphatic system cancer	0.000518	0.00153	CcSEcCtD
Enalapril—Paraesthesia—Bleomycin—lymphatic system cancer	0.00051	0.00151	CcSEcCtD
Enalapril—Dyspnoea—Bleomycin—lymphatic system cancer	0.000507	0.0015	CcSEcCtD
Enalapril—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000506	0.00149	CcSEcCtD
Enalapril—Confusional state—Carmustine—lymphatic system cancer	0.0005	0.00148	CcSEcCtD
Enalapril—Oedema—Carmustine—lymphatic system cancer	0.000496	0.00146	CcSEcCtD
Enalapril—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000496	0.00146	CcSEcCtD
Enalapril—Decreased appetite—Bleomycin—lymphatic system cancer	0.000494	0.00146	CcSEcCtD
Enalapril—Myalgia—Vincristine—lymphatic system cancer	0.000494	0.00146	CcSEcCtD
Enalapril—Visual disturbance—Methotrexate—lymphatic system cancer	0.000493	0.00146	CcSEcCtD
Enalapril—Cough—Mitoxantrone—lymphatic system cancer	0.000493	0.00146	CcSEcCtD
Enalapril—Vomiting—Fludarabine—lymphatic system cancer	0.000493	0.00145	CcSEcCtD
Enalapril—Rash—Fludarabine—lymphatic system cancer	0.000489	0.00144	CcSEcCtD
Enalapril—Dermatitis—Fludarabine—lymphatic system cancer	0.000488	0.00144	CcSEcCtD
Enalapril—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000486	0.00143	CcSEcCtD
Enalapril—Headache—Fludarabine—lymphatic system cancer	0.000486	0.00143	CcSEcCtD
Enalapril—Tachycardia—Carmustine—lymphatic system cancer	0.000484	0.00143	CcSEcCtD
Enalapril—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000483	0.00143	CcSEcCtD
Enalapril—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000481	0.00142	CcSEcCtD
Enalapril—Myalgia—Mitoxantrone—lymphatic system cancer	0.000481	0.00142	CcSEcCtD
Enalapril—Chest pain—Mitoxantrone—lymphatic system cancer	0.000481	0.00142	CcSEcCtD
Enalapril—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000477	0.00141	CcSEcCtD
Enalapril—Discomfort—Mitoxantrone—lymphatic system cancer	0.000475	0.0014	CcSEcCtD
Enalapril—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000474	0.0014	CcSEcCtD
Enalapril—Oedema—Vincristine—lymphatic system cancer	0.000474	0.0014	CcSEcCtD
Enalapril—Anorexia—Carmustine—lymphatic system cancer	0.000473	0.0014	CcSEcCtD
Enalapril—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000468	0.00138	CcSEcCtD
Enalapril—Confusional state—Mitoxantrone—lymphatic system cancer	0.000465	0.00137	CcSEcCtD
Enalapril—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000464	0.00137	CcSEcCtD
Enalapril—Hypotension—Carmustine—lymphatic system cancer	0.000464	0.00137	CcSEcCtD
Enalapril—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000461	0.00136	CcSEcCtD
Enalapril—Oedema—Mitoxantrone—lymphatic system cancer	0.000461	0.00136	CcSEcCtD
Enalapril—Nausea—Fludarabine—lymphatic system cancer	0.000461	0.00136	CcSEcCtD
Enalapril—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000458	0.00135	CcSEcCtD
Enalapril—Shock—Mitoxantrone—lymphatic system cancer	0.000454	0.00134	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000452	0.00133	CcSEcCtD
Enalapril—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000452	0.00133	CcSEcCtD
Enalapril—Urticaria—Bleomycin—lymphatic system cancer	0.000452	0.00133	CcSEcCtD
Enalapril—Anorexia—Vincristine—lymphatic system cancer	0.000452	0.00133	CcSEcCtD
Enalapril—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00045	0.00133	CcSEcCtD
Enalapril—Body temperature increased—Bleomycin—lymphatic system cancer	0.000449	0.00133	CcSEcCtD
Enalapril—Insomnia—Carmustine—lymphatic system cancer	0.000449	0.00132	CcSEcCtD
Enalapril—Irritability—Methotrexate—lymphatic system cancer	0.000446	0.00132	CcSEcCtD
Enalapril—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000446	0.00132	CcSEcCtD
Enalapril—Paraesthesia—Carmustine—lymphatic system cancer	0.000446	0.00132	CcSEcCtD
Enalapril—Hypotension—Vincristine—lymphatic system cancer	0.000443	0.00131	CcSEcCtD
Enalapril—Dyspnoea—Carmustine—lymphatic system cancer	0.000442	0.00131	CcSEcCtD
Enalapril—Somnolence—Carmustine—lymphatic system cancer	0.000441	0.0013	CcSEcCtD
Enalapril—Anorexia—Mitoxantrone—lymphatic system cancer	0.00044	0.0013	CcSEcCtD
Enalapril—Ataxia—Methotrexate—lymphatic system cancer	0.00044	0.0013	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000432	0.00127	CcSEcCtD
Enalapril—Decreased appetite—Carmustine—lymphatic system cancer	0.000431	0.00127	CcSEcCtD
Enalapril—Hypotension—Mitoxantrone—lymphatic system cancer	0.000431	0.00127	CcSEcCtD
Enalapril—Insomnia—Vincristine—lymphatic system cancer	0.000428	0.00126	CcSEcCtD
Enalapril—Paraesthesia—Vincristine—lymphatic system cancer	0.000425	0.00126	CcSEcCtD
Enalapril—Constipation—Carmustine—lymphatic system cancer	0.000424	0.00125	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000421	0.00124	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00042	0.00124	CcSEcCtD
Enalapril—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000419	0.00124	CcSEcCtD
Enalapril—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000414	0.00122	CcSEcCtD
Enalapril—Decreased appetite—Vincristine—lymphatic system cancer	0.000412	0.00122	CcSEcCtD
Enalapril—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000411	0.00121	CcSEcCtD
Enalapril—Somnolence—Mitoxantrone—lymphatic system cancer	0.00041	0.00121	CcSEcCtD
Enalapril—Feeling abnormal—Carmustine—lymphatic system cancer	0.000409	0.00121	CcSEcCtD
Enalapril—Fatigue—Vincristine—lymphatic system cancer	0.000408	0.00121	CcSEcCtD
Enalapril—Asthenia—Bleomycin—lymphatic system cancer	0.000408	0.0012	CcSEcCtD
Enalapril—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000406	0.0012	CcSEcCtD
Enalapril—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000406	0.0012	CcSEcCtD
Enalapril—Constipation—Vincristine—lymphatic system cancer	0.000405	0.0012	CcSEcCtD
Enalapril—Asthma—Methotrexate—lymphatic system cancer	0.000404	0.00119	CcSEcCtD
Enalapril—Pruritus—Bleomycin—lymphatic system cancer	0.000402	0.00119	CcSEcCtD
Enalapril—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000401	0.00118	CcSEcCtD
Enalapril—Eosinophilia—Methotrexate—lymphatic system cancer	0.0004	0.00118	CcSEcCtD
Enalapril—Fatigue—Mitoxantrone—lymphatic system cancer	0.000398	0.00117	CcSEcCtD
Enalapril—Pancreatitis—Methotrexate—lymphatic system cancer	0.000396	0.00117	CcSEcCtD
Enalapril—Constipation—Mitoxantrone—lymphatic system cancer	0.000394	0.00116	CcSEcCtD
Enalapril—Abdominal pain—Carmustine—lymphatic system cancer	0.000392	0.00116	CcSEcCtD
Enalapril—Body temperature increased—Carmustine—lymphatic system cancer	0.000392	0.00116	CcSEcCtD
Enalapril—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000387	0.00114	CcSEcCtD
Enalapril—Pancytopenia—Methotrexate—lymphatic system cancer	0.000384	0.00113	CcSEcCtD
Enalapril—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00038	0.00112	CcSEcCtD
Enalapril—Dysuria—Methotrexate—lymphatic system cancer	0.000378	0.00112	CcSEcCtD
Enalapril—Neutropenia—Methotrexate—lymphatic system cancer	0.000378	0.00112	CcSEcCtD
Enalapril—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000377	0.00111	CcSEcCtD
Enalapril—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000376	0.00111	CcSEcCtD
Enalapril—Abdominal pain—Vincristine—lymphatic system cancer	0.000374	0.00111	CcSEcCtD
Enalapril—Body temperature increased—Vincristine—lymphatic system cancer	0.000374	0.00111	CcSEcCtD
Enalapril—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000372	0.0011	CcSEcCtD
Enalapril—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000369	0.00109	CcSEcCtD
Enalapril—Urticaria—Mitoxantrone—lymphatic system cancer	0.000366	0.00108	CcSEcCtD
Enalapril—Hypersensitivity—Carmustine—lymphatic system cancer	0.000366	0.00108	CcSEcCtD
Enalapril—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000365	0.00108	CcSEcCtD
Enalapril—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000365	0.00108	CcSEcCtD
Enalapril—Pneumonia—Methotrexate—lymphatic system cancer	0.000362	0.00107	CcSEcCtD
Enalapril—Vomiting—Bleomycin—lymphatic system cancer	0.000361	0.00107	CcSEcCtD
Enalapril—Depression—Methotrexate—lymphatic system cancer	0.000359	0.00106	CcSEcCtD
Enalapril—Rash—Bleomycin—lymphatic system cancer	0.000358	0.00106	CcSEcCtD
Enalapril—Dermatitis—Bleomycin—lymphatic system cancer	0.000358	0.00106	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000357	0.00105	CcSEcCtD
Enalapril—Asthenia—Carmustine—lymphatic system cancer	0.000356	0.00105	CcSEcCtD
Enalapril—Renal failure—Methotrexate—lymphatic system cancer	0.000354	0.00105	CcSEcCtD
Enalapril—Stomatitis—Methotrexate—lymphatic system cancer	0.000351	0.00104	CcSEcCtD
Enalapril—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00035	0.00103	CcSEcCtD
Enalapril—Hypersensitivity—Vincristine—lymphatic system cancer	0.000349	0.00103	CcSEcCtD
Enalapril—Epistaxis—Methotrexate—lymphatic system cancer	0.00034	0.001	CcSEcCtD
Enalapril—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00034	0.001	CcSEcCtD
Enalapril—Asthenia—Vincristine—lymphatic system cancer	0.00034	0.001	CcSEcCtD
Enalapril—Diarrhoea—Carmustine—lymphatic system cancer	0.00034	0.001	CcSEcCtD
Enalapril—Nausea—Bleomycin—lymphatic system cancer	0.000338	0.000997	CcSEcCtD
Enalapril—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000336	0.000993	CcSEcCtD
Enalapril—Asthenia—Mitoxantrone—lymphatic system cancer	0.000331	0.000977	CcSEcCtD
Enalapril—Dizziness—Carmustine—lymphatic system cancer	0.000328	0.000968	CcSEcCtD
Enalapril—Diarrhoea—Vincristine—lymphatic system cancer	0.000324	0.000957	CcSEcCtD
Enalapril—Hepatitis—Methotrexate—lymphatic system cancer	0.000324	0.000955	CcSEcCtD
Enalapril—Pharyngitis—Methotrexate—lymphatic system cancer	0.000321	0.000948	CcSEcCtD
Enalapril—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000316	0.000932	CcSEcCtD
Enalapril—Vomiting—Carmustine—lymphatic system cancer	0.000316	0.000931	CcSEcCtD
Enalapril—Dizziness—Vincristine—lymphatic system cancer	0.000313	0.000924	CcSEcCtD
Enalapril—Rash—Carmustine—lymphatic system cancer	0.000313	0.000923	CcSEcCtD
Enalapril—Dermatitis—Carmustine—lymphatic system cancer	0.000313	0.000923	CcSEcCtD
Enalapril—Visual impairment—Methotrexate—lymphatic system cancer	0.000312	0.00092	CcSEcCtD
Enalapril—Headache—Carmustine—lymphatic system cancer	0.000311	0.000917	CcSEcCtD
Enalapril—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000306	0.000903	CcSEcCtD
Enalapril—Tinnitus—Methotrexate—lymphatic system cancer	0.000302	0.00089	CcSEcCtD
Enalapril—Vomiting—Vincristine—lymphatic system cancer	0.000301	0.000889	CcSEcCtD
Enalapril—Rash—Vincristine—lymphatic system cancer	0.000299	0.000881	CcSEcCtD
Enalapril—Dermatitis—Vincristine—lymphatic system cancer	0.000298	0.000881	CcSEcCtD
Enalapril—Headache—Vincristine—lymphatic system cancer	0.000297	0.000876	CcSEcCtD
Enalapril—Nausea—Carmustine—lymphatic system cancer	0.000295	0.00087	CcSEcCtD
Enalapril—Vomiting—Mitoxantrone—lymphatic system cancer	0.000293	0.000866	CcSEcCtD
Enalapril—Rash—Mitoxantrone—lymphatic system cancer	0.000291	0.000858	CcSEcCtD
Enalapril—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000291	0.000858	CcSEcCtD
Enalapril—Headache—Mitoxantrone—lymphatic system cancer	0.000289	0.000853	CcSEcCtD
Enalapril—Alopecia—Methotrexate—lymphatic system cancer	0.000286	0.000844	CcSEcCtD
Enalapril—Erythema—Methotrexate—lymphatic system cancer	0.000282	0.000831	CcSEcCtD
Enalapril—Nausea—Vincristine—lymphatic system cancer	0.000281	0.00083	CcSEcCtD
Enalapril—Dysgeusia—Methotrexate—lymphatic system cancer	0.000276	0.000814	CcSEcCtD
Enalapril—Nausea—Mitoxantrone—lymphatic system cancer	0.000274	0.000809	CcSEcCtD
Enalapril—Back pain—Methotrexate—lymphatic system cancer	0.000272	0.000804	CcSEcCtD
Enalapril—Vision blurred—Methotrexate—lymphatic system cancer	0.000265	0.000783	CcSEcCtD
Enalapril—Anaemia—Methotrexate—lymphatic system cancer	0.00026	0.000768	CcSEcCtD
Enalapril—Vertigo—Methotrexate—lymphatic system cancer	0.000253	0.000747	CcSEcCtD
Enalapril—Leukopenia—Methotrexate—lymphatic system cancer	0.000252	0.000744	CcSEcCtD
Enalapril—Cough—Methotrexate—lymphatic system cancer	0.000246	0.000725	CcSEcCtD
Enalapril—Arthralgia—Methotrexate—lymphatic system cancer	0.00024	0.000708	CcSEcCtD
Enalapril—Chest pain—Methotrexate—lymphatic system cancer	0.00024	0.000708	CcSEcCtD
Enalapril—Myalgia—Methotrexate—lymphatic system cancer	0.00024	0.000708	CcSEcCtD
Enalapril—Discomfort—Methotrexate—lymphatic system cancer	0.000237	0.000699	CcSEcCtD
Enalapril—Confusional state—Methotrexate—lymphatic system cancer	0.000232	0.000684	CcSEcCtD
Enalapril—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00023	0.000678	CcSEcCtD
Enalapril—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000225	0.000664	CcSEcCtD
Enalapril—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000222	0.000656	CcSEcCtD
Enalapril—Anorexia—Methotrexate—lymphatic system cancer	0.000219	0.000647	CcSEcCtD
Enalapril—Hypotension—Methotrexate—lymphatic system cancer	0.000215	0.000634	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000209	0.000618	CcSEcCtD
Enalapril—Insomnia—Methotrexate—lymphatic system cancer	0.000208	0.000614	CcSEcCtD
Enalapril—Paraesthesia—Methotrexate—lymphatic system cancer	0.000206	0.000609	CcSEcCtD
Enalapril—Dyspnoea—Methotrexate—lymphatic system cancer	0.000205	0.000605	CcSEcCtD
Enalapril—Somnolence—Methotrexate—lymphatic system cancer	0.000204	0.000603	CcSEcCtD
Enalapril—Dyspepsia—Methotrexate—lymphatic system cancer	0.000202	0.000597	CcSEcCtD
Enalapril—Decreased appetite—Methotrexate—lymphatic system cancer	0.0002	0.00059	CcSEcCtD
Enalapril—Fatigue—Methotrexate—lymphatic system cancer	0.000198	0.000585	CcSEcCtD
Enalapril—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000189	0.000559	CcSEcCtD
Enalapril—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000188	0.000555	CcSEcCtD
Enalapril—Urticaria—Methotrexate—lymphatic system cancer	0.000183	0.000539	CcSEcCtD
Enalapril—Abdominal pain—Methotrexate—lymphatic system cancer	0.000182	0.000536	CcSEcCtD
Enalapril—Body temperature increased—Methotrexate—lymphatic system cancer	0.000182	0.000536	CcSEcCtD
Enalapril—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000169	0.0005	CcSEcCtD
Enalapril—Asthenia—Methotrexate—lymphatic system cancer	0.000165	0.000487	CcSEcCtD
Enalapril—Pruritus—Methotrexate—lymphatic system cancer	0.000163	0.00048	CcSEcCtD
Enalapril—Diarrhoea—Methotrexate—lymphatic system cancer	0.000157	0.000464	CcSEcCtD
Enalapril—Dizziness—Methotrexate—lymphatic system cancer	0.000152	0.000449	CcSEcCtD
Enalapril—Vomiting—Methotrexate—lymphatic system cancer	0.000146	0.000431	CcSEcCtD
Enalapril—Rash—Methotrexate—lymphatic system cancer	0.000145	0.000428	CcSEcCtD
Enalapril—Dermatitis—Methotrexate—lymphatic system cancer	0.000145	0.000427	CcSEcCtD
Enalapril—Headache—Methotrexate—lymphatic system cancer	0.000144	0.000425	CcSEcCtD
Enalapril—Nausea—Methotrexate—lymphatic system cancer	0.000137	0.000403	CcSEcCtD
